Kymera Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Kymera Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kymera Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kymera Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $10M | 396k | 25.46 |
| 2023-09-30 | $3.3M | 239k | 13.90 |
| 2023-06-30 | $7.1M | 307k | 22.99 |
| 2023-03-31 | $1.0M | 34k | 29.63 |
| 2022-12-31 | $4.8M | 192k | 24.96 |
| 2022-06-30 | $3.3M | 166k | 19.69 |
| 2022-03-31 | $4.0M | 96k | 42.33 |
| 2021-12-31 | $2.6M | 41k | 63.48 |
| 2021-09-30 | $7.4M | 126k | 58.74 |
| 2021-06-30 | $3.0M | 63k | 48.49 |
| 2021-03-31 | $4.8M | 125k | 38.86 |